BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16459250)

  • 1. Antipsychotics and the risk of diabetes: a general data review.
    Bottai T; Quintin P; Perrin E
    Eur Psychiatry; 2005 Dec; 20 Suppl 4():S349-57. PubMed ID: 16459250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotic drugs. Risk factors for diabetes].
    Stip E; Tranulis C; Légaré N; Poulin MJ
    Presse Med; 2003 Oct; 32(34):1612-7. PubMed ID: 14576587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
    Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
    Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
    Ollendorf DA; Joyce AT; Rucker M
    MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for diabetes in hospitalised patients prescribed antipsychotic drugs.
    Taylor D; Young C; Esop R; Paton C; Walwyn R
    Br J Psychiatry; 2004 Aug; 185():152-6. PubMed ID: 15286067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
    Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus and atypical antipsychotics].
    de Sena EP; Sampaio AS; Quarantini Lde C; Oliveira IR
    Braz J Psychiatry; 2003 Oct; 25(4):253-7. PubMed ID: 15328554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics and diabetes mellitus.
    Lichiardopol R
    Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between antipsychotic drugs and diabetes.
    Holt RI; Peveler RC
    Diabetes Obes Metab; 2006 Mar; 8(2):125-35. PubMed ID: 16448516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists.
    Newcomer JW; Nasrallah HA; Loebel AD
    J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S1-6. PubMed ID: 15356414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics and glucose homeostasis.
    Bergman RN; Ader M
    J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.
    Luft B; Taylor D
    Expert Opin Pharmacother; 2006 Sep; 7(13):1739-48. PubMed ID: 16925501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
    Cohen D
    Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
    Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
    Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and antipsychotic treatment in the United Kingdom.
    Carlson C; Hornbuckle K; DeLisle F; Kryzhanovskaya L; Breier A; Cavazzoni P
    Eur Neuropsychopharmacol; 2006 Jul; 16(5):366-75. PubMed ID: 16356695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
    Citrome L; Jaffe A; Levine J; Allingham B; Robinson J
    Psychiatr Serv; 2004 Sep; 55(9):1006-13. PubMed ID: 15345760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.
    Gianfrancesco F; Pesa J; Wang RH; Nasrallah H
    Am J Health Syst Pharm; 2006 Mar; 63(5):431-41. PubMed ID: 16484517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.